# Change of Address; Abbreviated New Drug Applications; Technical Amendment
> **Food and Drug Administration** · Final rule; technical amendment. · Published 2010-06-29 · Effective 2010-08-01 · 75 FR 37295
## Document
- **Document number:** 2010-15711
- **Category:** fda-drug
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 75 FR 37295
- **CFR reference:** 21 CFR 312
- **Publication date:** 2010-06-29
- **Effective date:** 2010-08-01
- **HHS docket:** Docket No. FDA-2010-N-0010
## Abstract

The Food and Drug Administration (FDA) is amending its regulations to update the address for applicants to submit abbreviated new drug applications (ANDAs) and ANDA amendments, supplements, and resubmissions. FDA is also updating the address for ANDA applicants to submit investigational new drug applications (INDs) for in vivo bioavailability and bioequivalence studies in humans that are intended to support ANDAs. This action is being taken to ensure accuracy and clarity in the agency's regulations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2010/06/29/2010-15711/change-of-address-abbreviated-new-drug-applications-technical-amendment)
---
*AI Analytics · CC0 1.0*